跳至主要内容
临床试验/NCT02160184
NCT02160184已完成不适用

Nocturnal Insulin-Glucose in Hospital: Tight Control

Corporacion Parc Tauli2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
2
主要终点
Percentage of time in target range (3.9-8.0 mmol/l) YSI glucose during the in clinic overnight visit.

研究概览

简要总结

The aim of the study is to assess the efficacy and safety of a closed-loop system consisting of a predictive rule-based algorithm integrated on the Medtronic Portable Glucose Control System (PGCS) in patients with type 1 diabetes for controlling the nocturnal and post-breakfast periods. Intervention will be to apply the automated closed-loop system by administering a subcutaneous insulin microbolus every 5 minutes depending on reading from a continuous glucose measurement (CGM) system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 1 Diabetes
  • Diabetes duration > 3 years
  • Continuous Subcutaneous Insulin Infusion (CSII) treatment for more than 1 year
  • No ketoacidosis during the previous 12 months
  • Glomerular Filtration Rate (GFR) > 60 ml/kg/min m2
  • Willingness of participate and signed and dated written informed consent in accordance with Good Clinical Practice

排除标准

  • Gastroparesis
  • Hypoglycemia unawareness
  • Uncorrected visual impairment
  • BMI> 35 kg/m2

结局指标

主要结局

Percentage of time in target range (3.9-8.0 mmol/l) YSI glucose during the in clinic overnight visit.

时间窗: During the closed-loop period for each patient: 12 hours

次要结局

未报告次要终点

研究者

发起方
Corporacion Parc Tauli
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mercedes Rigla

MD, PhD

Corporacion Parc Tauli

研究点 (2)

Loading locations...

相似试验